Tablets & Capsules


Issue link:

Contents of this Issue


Page 58 of 79

l-BN-44-47_Masters 12/30/13 2:08 PM Page 45 January 2014 45 Tablets & Capsules Center. Tel. +49 762 1664 308. Fax +49 762 1166 4798. Website: www. DCAT Week. March 10-13 in New York, NY. Conducted by the Drug, Chemical, & Associated Technologies Association. Tel. 609 448 1000. Fax 609 448 1944. Website: Fluidized Bed Processing. March 11-13 in Binzen, Germany. Con ducted by the Technology Training Center. Tel. +49 762 1664 308. Fax +49 762 1167 99 200. Website: Secrets of Batch Process ScaleUp. March 11-13 in Boston, MA. Conducted by Scientific Update. Tel. +44 1435 873 062. Fax +44 1435 872 734. Website: www.scientificupdate. Tablet Pro II. March 11-14 in Cleveland, OH. Conducted by Techceuticals. Tel. 216 658 8038. Website: 21 CFR 111 Dietary Supplement GMP Overview. March 18 in Long Island, NY. Conducted by NSF. Tel. 734 827 5600. Website: INTERPHEX. March 18-20 in New York, NY. Conducted by Reed Exhibitions. Tel. 203 840 5648. Fax 203 840 9648. Website: Pharma Forum. March 23-26 in Orlando, FL. Conducted by CBI. Tel. 339 298 2200. Fax 781 939 2490. Website: Dissolution Testing of Capsules. March 24-25 in Rockville, MD. Conducted by US Pharmacopeia. Tel. 301 881 0666. Fax 301 816 8148. Website: supplier news company. JLL will contribute $489 million to the deal, and DSM will contribute its pharmaceutical products division and receive a seller's note of $200 million. Once complete, the transaction will give JLL a 51 percent stake and DSM a 49 percent stake in the new company. Gamlen awarded development grant NOTTINGHAM, UK—Gamlen Tableting won funding from the government-backed Technology Stra tegy Board's SMART program. The award will allow Gamlen to improve its R&D tablet press, especially in data management and automatic measurement of detachment (takeoff) force. Bend Research to expand BEND, OR—Bend Research plans to expand its commercial manufacturing facility for spray-dried dispersions, adding 6,000 to 8,000 square feet to its current 12,000-square-foot site. The $20 million investment for Colorcon, Evonik to cooperate on enteric coating HARLEYSVILLE, PA—Colorcon and Evonik, Essen, Germany, agreed to jointly market and provide technical support for Acryl-Eze, a fully formulated aqueous acrylic enteric coating system that uses Evonik's anionic copolymer, Eudragit L 100-55. Customers with enteric coating projects will have access to nine Evonik technology centers and 20 of Colorcon's global technical services laboratories. Bohle invests in continuous production WARMINSTER, PA—L.B. Bohle plans to invest $8 million to $11 million over the next 3 years to build a technology center in Ennigerloh, Ger- Tablet de-dusting solutions from the Global Leader For 35 YEARS the pharmaceutical industry has relied upon to de-dust, de-burr and convey tablets with the highest efficiency. To learn more about the how to EFFICIENCY of your tableting lines contact Kraemer U.S. DSM, JLL private equity buy Patheon, launch new company HEERLEN, Netherlands—Royal DSM and private equity firm JLL plan to purchase Patheon, Durham, NC, and combine it with DSM's pharmaceutical arm to launch a new the expansion comes from Capsugel, Morristown, NJ, which acquired Bend Research in September 2013 as part of its Dosage Form Solutions (DFS) business unit. Allendale, New Jersey

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0114